TegoScience Inc.

A191420

KR7191420009

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-16 EDT			5-day change	1st Jan Change
20,900 ^KRW	-0.24%		-4.78%	+42.56%

2023	TegoScience Inc.(KOSDAQ:A191420) dropped from S&P Global BMI Index	CI
2023	TegoScience Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

TegoScience Inc.'s Equity Buyback Plan Extended till March 15, 2021.

September 14, 2020

On September 15, 2020, the company announced that it has extended its plan duration till March 15, 2021.

Latest news about TegoScience Inc.

TegoScience Inc.(KOSDAQ:A191420) dropped from S&P Global BMI Index	23-09-18	CI
TegoScience Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
TegoScience Inc.'s Equity Buyback announced on March 16, 2020, has expired.	22-03-14	CI
TegoScience Inc.'s Equity Buyback Plan Extended till September 15, 2021.	21-03-14	CI
TegoScience Inc.'s Equity Buyback Plan Extended till March 15, 2021.	20-09-14	CI
Tranche Update on TegoScience Inc.'s Equity Buyback Plan announced on March 16, 2020.	20-06-19	CI
TegoScience Inc. announces an Equity Buyback for KRW 2,000 million worth of its shares.	20-03-16	CI
Tego Science, Inc. authorizes a Buyback Plan.	20-03-15	CI
TegoScience Inc. announced that it has received KRW 15 billion in funding from Korea Investment Capital Co., Ltd, LIG Investment & Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm	16-10-20	CI
TegoScience Inc. announced that it expects to receive KRW 15 billion in funding from Korea Investment Capital Co., Ltd, LIG Investment & Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm	16-10-18	CI
TegoScience Inc.(KOSDAQ:A191420) added to S&P Global BMI Index	16-09-19	CI
TegoScience Inc. announced that it has received KRW 1 billion in funding	16-06-28	CI
TegoScience Inc. announced that it expects to receive KRW 1 billion in funding	16-06-26	CI
National Pension Service and a related party acquired 5.21% stake in TegoScience Inc..	15-07-08	CI
TegoScience Inc. has completed an IPO in the amount of KRW 7,191.44 million.	14-11-04	CI
TegoScience Inc. has filed an IPO in the amount of KRW 6,658 million.	14-07-10	CI

Tego Science,Inc. is a Korea-based company mainly engaged in the research and development, manufacture and distribution of wound-healing skin cell therapy products. The Companyâs products mainly consist of cell therapy products, and laboratory cultured skin models.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
TEGOSCIENCE INC.	+42.56%	124M
CSL LIMITED	-2.32%	90.45B
SAMSUNG BIOLOGICS CO.,LTD.	+3.68%	41.45B
BIOGEN INC.	-10.90%	33.57B
BIOMARIN PHARMACEUTICAL INC.	-19.56%	14.73B
INCYTE CORPORATION	-9.06%	12.82B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.34%	11.7B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.53%	11.44B
SWEDISH ORPHAN BIOVITRUM AB	+3.75%	8.79B
INNOVENT BIOLOGICS, INC.	-6.32%	8.35B

Biopharmaceuticals

TegoScience Inc.

Equities

A191420

KR7191420009

Pharmaceuticals

TegoScience Inc.'s Equity Buyback Plan Extended till March 15, 2021.

Latest news about TegoScience Inc.

Chart TegoScience Inc.

Company Profile

Income Statement Evolution

Sector Biopharmaceuticals